Cluster | Total UMI counts | Global CPM | Transcripts | Categories | Human homolog | Annotation |
---|---|---|---|---|---|---|
MligTC455_20782 | 91 | 1.90 | Mlig455_066519 | Neo: - Age: Up-Down-Down, logFC(26M/2M)=-1.321 Region-enriched R8: 5.950/0.00576 |
Mlig455_066519 {REF} {Length: 3710} {RNA1509_53671} {RNA1310_35957.1} {RNA815_13121.1} |
Region | logFC | logCPM | Pvalue | FDR | Specificity |
---|---|---|---|---|---|
RegionR1 | 0.393 | 1.193 | 0.99958 | 1.00000 | |
RegionR2 | -3.914 | 1.193 | 0.99940 | 1.00000 | |
RegionR3 | -3.075 | 1.193 | 0.99932 | 1.00000 | |
RegionR4 | 1.329 | 1.193 | 0.18878 | 0.46300 | |
RegionR5 | -2.745 | 1.193 | 0.99917 | 1.00000 | |
RegionR6 | -3.269 | 1.193 | 0.99911 | 1.00000 | |
RegionR7 | 5.33 | 1.193 | 0.00021 | 0.01039 | |
RegionR8 | 5.95 | 1.193 | 0.00006 | 0.00576 |
Region | logFC | logCPM | PValue | FDR | Specificity |
---|---|---|---|---|---|
RegenerationR1 | -2.567 | 1.193 | 1.00000 | 1.00000 | |
RegenerationR2 | 1.988 | 1.193 | 0.22768 | 0.67553 | |
RegenerationR3 | 0.937 | 1.193 | 0.51019 | 0.86139 | |
RegenerationR4 | -0.232 | 1.193 | 0.75782 | 0.97209 | |
RegenerationR5 | 1.825 | 1.193 | 0.29088 | 0.71876 | |
RegenerationR6 | 3.408 | 1.193 | 0.17063 | 0.50186 | |
RegenerationBL | -5.419 | 1.193 | 1.00000 | 1.00000 | |
RegenerationTP | -0.176 | 1.193 | 0.82667 | 1.00000 |
Nr. | Cluster | Total UMI counts | Global CPM | Transcripts | Categories | Human homolog | Σ Spearman correlations | Int1 | Int2 | Int3 | Reg1 | Reg2 | Reg3 | Annotation |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1. | MligTC455_20782 | 91 | 1.9 | Mlig455_066519 | Neo: - Age: Up-Down-Down, logFC(26M/2M)=-1.321 Region-enriched R8: 5.950/0.00576 |
2 | 1.000 | - | - | - | 1.000 | - | Mlig455_066519 {REF} {Length: 3710} {RNA1509_53671} {RNA1310_35957.1} {RNA815_13121.1} | |
2. | MligTC455_38796 | 1266 | 26.37 | Mlig455_060220, Mlig455_060235 | Neo: - Age: Down-Down-Up Region-enriched R8: 6.521/0.00003 |
BACE1 | 1.852 | 0.992 | - | - | - | 0.860 | - | Mlig455_060220 {REF} {Length: 1841} {Pfam: Eukaryotic aspartyl protease [PF00026.25, score=72.8]; Xylanase inhibitor C-terminal [PF14541.8, score=19.9]} {Human: ENSG00000186318, BACE1, beta-secretase 1, [Score=215, Expect=3e-63]} {Mouse: ENSMUSG00000032086, Bace1, beta-site APP cleaving enzyme 1, [Score=214, Expect=5e-63]} {Dmel: FBgn0032304, CG17134, [Score=56.2, Expect=3e-08]} {Celegans: WBGene00000218, asp-5, ASpartyl Protease, [Score=47.8, Expect=1e-05]} {RNA1509_48153} {RNA1310_17192, RNA1509_48153} {RNA1509_48153, RNA815_50706} Mlig455_060235 {REF} {Length: 1482} {Human: ENSG00000186318, BACE1, beta-secretase 1, [Score=119, Expect=2e-29]} {Mouse: ENSMUSG00000032086, Bace1, beta-site APP cleaving enzyme 1, [Score=118, Expect=1e-28]} {RNA1509_48153} {RNA1310_17192} {RNA815_51940} |
3. | MligTC455_20780 | 8892 | 185.26 | Mlig455_040314 | Neo: - Age: logFC(26M/2M)=-1.054 Region-enriched R8: 6.072/0.00000 |
NOTCH2 | 1.844 | 0.979 | - | - | - | 0.865 | - | Mlig455_040314 {REF} {Length: 15786} {Pfam: EGF domain [PF12947.9, score=500.6]; Calcium-binding EGF domain [PF07645.17, score=489.8]; Complement Clr-like EGF-like [PF12662.9, score=268.7]; EGF-like domain [PF00008.29, score=175.9]; Human growth factor-like EGF [PF12661.9, score=135.4]; MSP1 EGF domain 1 [PF12946.9, score=91.5]; von Willebrand factor type D domain [PF00094.27, score=75.8]; Coagulation Factor Xa inhibitory site [PF14670.8, score=51.8]; Pvs28 EGF domain [PF06247.13, score=34.2]; Trypsin Inhibitor like cysteine rich domain [PF01826.19, score=25.7]} {Human: ENSG00000134250, NOTCH2, notch 2, [Score=246, Expect=4e-64]; ENSG00000138829, FBN2, fibrillin 2, [Score=237, Expect=3e-61]} {Mouse: ENSMUSG00000027878, Notch2, notch 2, [Score=249, Expect=6e-65]} {Dmel: FBgn0053196, dpy, dumpy, [Score=343, Expect=2e-93]} {Celegans: WBGene00022816, fbn-1, FBN-1A.1; FiBrilliN homolog, [RH, Score=254, Expect=5e-67]} {Smed: dd_Smed_v6_2649_0_2, dd_Smed_v6_2649_0_2, [Score=415, Expect=3e-115]} {RNA1509_11248, RNA1509_12416, RNA1509_21118, RNA1509_37363, RNA1509_39736, RNA1509_45308, RNA1509_5454, RNA1509_57584, RNA1509_59762, RNA1509_770, RNA1509_9237} {RNA1310_1209, RNA1509_11248, RNA1509_12416, RNA1509_21118, RNA1509_37363, RNA1509_39736, RNA1509_45308, RNA1509_5454, RNA1509_57584, RNA1509_59762, RNA1509_9237} {RNA1509_11248, RNA1509_12416, RNA1509_21118, RNA1509_37363, RNA1509_39736, RNA1509_45308, RNA1509_5454, RNA1509_57584, RNA1509_59762, RNA1509_9237, RNA815_317.1} |
4. | MligTC455_13018 | 1993 | 41.51 | Mlig455_033923 | Neo: - Age: Down-Up-Down, logFC(26M/2M)=-0.482 Region-enriched R8: 5.842/0.00000 |
1.842 | 0.994 | - | - | - | 0.848 | - | Mlig455_033923 {REF} {Length: 1258} {RNA1509_17580, RNA1509_20381, RNA1509_25516, RNA1509_52130} {RNA1310_45334, RNA1509_17580, RNA1509_20381, RNA1509_25516, RNA1509_52130} {RNA1509_17580, RNA1509_20381, RNA1509_25516, RNA1509_52130, RNA815_5573.2} | |
5. | MligTC455_07961 | 191 | 3.98 | Mlig455_051526 | Neo: - Age: - Region-enriched R8: 7.862/0.00000 Regeneration-enriched R5: 7.080 |
1.837 | 0.988 | - | - | - | 0.849 | - | Mlig455_051526 {REF} {Length: 437} {RNA815_63444} | |
6. | MligTC455_03038 | 227 | 4.72 | Mlig455_060778 | Neo: - Age: Down-Up-Down Region-enriched R8: 6.261/0.00000 |
1.835 | 0.981 | - | - | - | 0.854 | - | Mlig455_060778 {REF} {Length: 4155} {TRANSSPLICED} {tRNA: Val(CAC),pseudo, score=27.8} {Mouse: ENSMUSG00000059854, Hydin, HYDIN, axonemal central pair apparatus protein, [Score=55.1, Expect=5e-07]} {RNA1509_16236} {RNA1310_4008} {RNA815_2550} | |
7. | MligTC455_20781 | 5503 | 114.65 | Mlig455_066518 | Neo: - Age: Up-Down-Down, logFC(26M/2M)=-0.978 Region-enriched R8: 6.430/0.00000 |
FBN2 | 1.831 | 0.985 | - | - | - | 0.846 | - | Mlig455_066518 {REF} {Length: 6133} {Pfam: EGF domain [PF12947.9, score=539.9]; Calcium-binding EGF domain [PF07645.17, score=534.2]; Complement Clr-like EGF-like [PF12662.9, score=301.4]; EGF-like domain [PF00008.29, score=202.5]; Human growth factor-like EGF [PF12661.9, score=158.8]; MSP1 EGF domain 1 [PF12946.9, score=133.7]; Coagulation Factor Xa inhibitory site [PF14670.8, score=101.2]; Pvs28 EGF domain [PF06247.13, score=76.5]; Trypsin Inhibitor like cysteine rich domain [PF01826.19, score=27.8]} {Human: ENSG00000138829, FBN2, fibrillin 2, [Score=348, Expect=8e-98]} {Mouse: ENSMUSG00000024598, Fbn2, fibrillin 2, [Score=350, Expect=2e-98]} {Dmel: FBgn0053196, dpy, dumpy, [Score=343, Expect=2e-96]} {Celegans: WBGene00022816, fbn-1, FBN-1A.1; FiBrilliN homolog, [RH, Score=268, Expect=2e-72]} {Smed: dd_Smed_v6_2649_0_2, dd_Smed_v6_2649_0_2, [Score=426, Expect=1e-123]} {RNA1509_12396, RNA1509_21908, RNA1509_41091, RNA1509_6746, RNA1509_770} {RNA1310_1209, RNA1509_12396, RNA1509_21908, RNA1509_41091, RNA1509_6746} {RNA1509_12396, RNA1509_21908, RNA1509_41091, RNA1509_6746, RNA815_317.1} |
8. | MligTC455_20404 | 2355 | 49.05 | Mlig455_053980 | Neo: - Age: - Region-enriched R7: 4.495/0.00000 Regeneration-downregulated BL: -4.662 Regeneration-depleted BL: -4.662 |
1.829 | 0.950 | - | - | - | 0.879 | - | Mlig455_053980 {REF} {Length: 505} {NoTransDecoderORF} {RNA1509_5548} {RNA1310_94516} {RNA815_53532} | |
9. | MligTC455_20407 | 5467 | 113.89 | Mlig455_054055 | Neo: - Age: Down-Up-Up, logFC(26M/2M)=0.662 Region-enriched R7: 3.793/0.00000 Regeneration-downregulated BL: -5.435 Regeneration-depleted BL: -5.435 |
1.821 | 0.953 | - | - | - | 0.868 | - | Mlig455_054055 {REF} {Length: 1179} {RNA1509_40983} {RNA1310_94516} {RNA815_53532} | |
10. | MligTC455_22921 | 848 | 17.66 | Mlig455_048030 | Neo: - Age: - Region-enriched R8: 6.496/0.00000 Regeneration-downregulated BL: -8.561 Regeneration-depleted BL: -8.561 |
CNTNAP1 | 1.821 | 0.957 | - | - | - | 0.864 | - | Mlig455_048030 {REF} {Length: 2506} {Pfam: Thrombospondin type 1 domain [PF00090.21, score=31.2]; Spondin-like TSP1 domain [PF19028.2, score=23.9]; Thrombospondin type 1 domain [PF19030.2, score=20.8]} {Human: ENSG00000108797, CNTNAP1, contactin associated protein 1, [Score=65.5, Expect=3e-11]} {Mouse: ENSMUSG00000017167, Cntnap1, contactin associated protein-like 1, [Score=69.3, Expect=1e-12]} {Dmel: FBgn0013997, Nrx-IV, Neurexin IV, [Score=63.5, Expect=6e-11]} {Celegans: WBGene00003772, nlr-1, Neurexin Like receptor, [Score=60.8, Expect=3e-10]} {Smed: dd_Smed_v6_2622_0_1, dd_Smed_v6_2622_0_1, [Score=70.5, Expect=2e-13]} {RNA1509_12135} {RNA1310_13292} {RNA815_6015.1} |
11. | MligTC455_20400 | 4609 | 96.03 | Mlig455_007551, Mlig455_011814 | Neo: - Age: Up-Up-Up, logFC(26M/2M)=1.242 Region-enriched R7: 5.211/0.00000 Regeneration-downregulated BL: -6.608 Regeneration-depleted BL: -6.608 |
1.817 | 0.952 | - | - | - | 0.865 | - | Mlig455_007551 {REF} {Length: 486} {RNA1509_8862} {RNA1310_107754, RNA1509_8862} {RNA1509_8862, RNA815_47935} Mlig455_011814 {REF} {Length: 367} {RNA1509_8862} {RNA1310_107754} {RNA815_47935} |
|
12. | MligTC455_06181 | 524 | 10.92 | Mlig455_030220, Mlig455_067996 | Neo: - Age: Down-Up-Down Region-enriched R8: 6.634/0.00000 |
1.816 | 0.951 | - | - | - | 0.865 | - | Mlig455_030220 {REF} {Length: 1310} {Pfam: Spt20 family [PF12090.10, score=21.7]} {RNA1310_56165} {RNA815_14421} Mlig455_067996 {REF} {Length: 1307} {RNA1310_56165} {RNA815_14421} |
|
13. | MligTC455_20401 | 11443 | 238.4 | Mlig455_013098, Mlig455_013191 | Neo: - Age: Up-Down-Up Region-enriched R7: 5.239/0.00000 Regeneration-downregulated BL: -6.183 Regeneration-depleted BL: -6.183 |
1.812 | 0.960 | - | - | - | 0.852 | - | Mlig455_013098 {REF} {Length: 379} {RNA1509_2705} {RNA1310_107754} {RNA815_47935} Mlig455_013191 {REF} {Length: 379} {RNA1509_2705} {RNA1310_107754} {RNA815_47935} |
|
14. | MligTC455_48650 | 8593 | 179.02 | Mlig455_043924 | Neo: - Age: logFC(26M/2M)=-0.454 Region-enriched R8: 6.377/0.00000 |
1.801 | 0.976 | - | - | - | 0.825 | - | Mlig455_043924 {REF} {Length: 1776} {RNA1509_3829} {RNA1310_39915.1, RNA1509_3829} {RNA1509_3829, RNA815_21876} | |
15. | MligTC455_31520 | 9547 | 198.9 | Mlig455_055402 | Neo: - Age: logFC(26M/2M)=-0.427 Region-enriched R8: 7.718/0.00000 |
PI16 | 1.789 | 0.956 | - | - | - | 0.833 | - | Mlig455_055402 {REF} {Length: 1363} {Pfam: Cysteine-rich secretory protein family [PF00188.28, score=27.4]} {Human: ENSG00000164530, PI16, peptidase inhibitor 16, [Score=69.3, Expect=4e-13]; ENSG00000173401, GLIPR1L1, GLIPR1 like 1, [Score=67.8, Expect=4e-13]} {Mouse: ENSMUSG00000024011, Pi16, peptidase inhibitor 16, [Score=71.2, Expect=7e-14]} {Dmel: FBgn0038126, CG8483, [Score=55.8, Expect=6e-09]} {Celegans: WBGene00009890, scl-9, SCP-Like extracellular protein, [Score=50.4, Expect=1e-07]} {Smed: dd_Smed_v6_924_0_2, dd_Smed_v6_924_0_2, [Score=87.0, Expect=1e-21]} {RNA1509_603} {RNA1310_25676} {RNA815_7928} |
16. | MligTC455_31519 | 9556 | 199.07 | Mlig455_055347 | Neo: - Age: Down-Down-Up, logFC(26M/2M)=-0.365 Region-enriched R8: 7.870/0.00000 |
PI16 | 1.787 | 0.956 | - | - | - | 0.831 | - | Mlig455_055347 {REF} {Length: 1681} {Pfam: Cysteine-rich secretory protein family [PF00188.28, score=56.5]; Kringle domain [PF00051.20, score=52.7]} {Human: ENSG00000164530, PI16, peptidase inhibitor 16, [Score=84.3, Expect=2e-17]} {Mouse: ENSMUSG00000024011, Pi16, peptidase inhibitor 16, [Score=82.4, Expect=6e-17]} {Dmel: FBgn0038126, CG8483, [Score=97.4, Expect=2e-22]} {Celegans: WBGene00003055, lon-1, LONg, [Score=65.1, Expect=9e-12]} {Smed: dd_Smed_v6_433_0_1, dd_Smed_v6_433_0_1, [Score=111, Expect=3e-29]} {RNA1509_603} {RNA1310_25676} {RNA815_7928} |
17. | MligTC455_31518 | 19118 | 398.29 | Mlig455_053864, Mlig455_053878 | Neo: - Age: Down-Down-Up, logFC(26M/2M)=2.053 Region-enriched R8: 7.674/0.00000 |
PI16 | 1.785 | 0.956 | - | - | - | 0.829 | - | Mlig455_053864 {REF} {Length: 1794} {Pfam: Cysteine-rich secretory protein family [PF00188.28, score=56.1]; Kringle domain [PF00051.20, score=52.3]} {Human: ENSG00000164530, PI16, peptidase inhibitor 16, [Score=100, Expect=1e-22]} {Mouse: ENSMUSG00000024011, Pi16, peptidase inhibitor 16, [Score=99.0, Expect=3e-22]} {Dmel: FBgn0038126, CG8483, [Score=102, Expect=1e-23]} {Celegans: WBGene00011724, scl-18, SCP-Like extracellular protein, [RH, Score=73.2, Expect=1e-14]} {Smed: dd_Smed_v6_924_0_1, dd_Smed_v6_924_0_1, [RH, Score=128, Expect=3e-35]} {RNA1509_603} {RNA1310_25676} {RNA815_7928} Mlig455_053878 {REF} {Length: 1368} {Pfam: Cysteine-rich secretory protein family [PF00188.28, score=56.1]; Kringle domain [PF00051.20, score=52.3]} {Human: ENSG00000164530, PI16, peptidase inhibitor 16, [Score=100, Expect=1e-22]} {Mouse: ENSMUSG00000024011, Pi16, peptidase inhibitor 16, [Score=99.0, Expect=3e-22]} {Dmel: FBgn0038126, CG8483, [Score=102, Expect=1e-23]} {Celegans: WBGene00011724, scl-18, SCP-Like extracellular protein, [RH, Score=73.2, Expect=1e-14]} {Smed: dd_Smed_v6_924_0_1, dd_Smed_v6_924_0_1, [RH, Score=128, Expect=3e-35]} {RNA1509_603} {RNA1310_25676} {RNA815_7928} |
18. | MligTC455_14375 | 163 | 3.4 | Mlig455_056945 | Neo: - Age: - |
0.995 | 0.995 | - | - | - | - | - | Mlig455_056945 {REF} {Length: 1764} {Pfam: Glycosyltransferase sugar-binding region containing DXD motif [PF04488.17, score=49.6]} {Smed: dd_Smed_v6_32358_0_1, dd_Smed_v6_32358_0_1, [Score=94.4, Expect=4e-22]} {RNA1509_48719} {RNA1310_16266.1} {RNA815_10544.2} | |
19. | MligTC455_44435 | 628 | 13.08 | Mlig455_062382, Mlig455_062409 | Neo: - Age: Up-Down-Up, logFC(26M/2M)=-0.421 Region-enriched R8: 5.635/0.00000 |
DDI2, HMCN1 | 0.995 | 0.995 | - | - | - | - | - | Mlig455_062382 {REF} {Length: 12544} {TRANSSPLICED} {Pfam: Aspartyl protease [PF09668.12, score=182.5]; gag-polyprotein putative aspartyl protease [PF13975.8, score=76.1]; Thrombospondin type 1 domain [PF00090.21, score=72.3]; Spondin-like TSP1 domain [PF19028.2, score=68.4]; Arginine repressor, C-terminal domain [PF02863.20, score=43.6]; Aspartyl protease [PF13650.8, score=34.4]; Putative vacuolating cytotoxin [PF03077.16, score=29.0]; Ubiquitin-2 like Rad60 SUMO-like [PF11976.10, score=26.1]; Thrombospondin type 1 domain [PF19030.2, score=23.0]; CCN3 Nov like TSP1 domain [PF19035.2, score=22.2]; Retroviral aspartyl protease [PF00077.22, score=19.1]} {Human: ENSG00000197312, DDI2, DNA damage inducible 1 homolog 2, [Score=279, Expect=2e-82]} {Mouse: ENSMUSG00000078515, Ddi2, DNA-damage inducible protein 2, [Score=266, Expect=5e-78]; ENSMUSG00000047619, Ddi1, DNA-damage inducible 1, [Score=255, Expect=4e-74]} {Dmel: FBgn0030753, rngo, rings lost, [Score=275, Expect=1e-80]} {Celegans: WBGene00015308, ddi-1, Dna (DNA) Damage Inducible homolog, [Score=131, Expect=5e-32]} {Smed: dd_Smed_v6_2764_0_1, dd_Smed_v6_2764_0_1, [Score=213, Expect=1e-60]} {RNA1509_6950} {RNA1310_548} {RNA815_300} Mlig455_062409 {REF} {Length: 19342} {Pfam: Spondin-like TSP1 domain [PF19028.2, score=78.9]; Thrombospondin type 1 domain [PF00090.21, score=74.6]; Arginine repressor, C-terminal domain [PF02863.20, score=41.0]; Trypsin Inhibitor like cysteine rich domain [PF01826.19, score=40.0]; CCN3 Nov like TSP1 domain [PF19035.2, score=32.2]; Putative vacuolating cytotoxin [PF03077.16, score=30.3]; Thrombospondin type 1 domain [PF19030.2, score=23.2]} {Human: ENSG00000143341, HMCN1, hemicentin 1, [Score=90.1, Expect=7e-17]} {Mouse: ENSMUSG00000066842, Hmcn1, hemicentin 1, [Score=90.5, Expect=4e-17]} {Dmel: FBgn0050046, CG30046, [Score=52.4, Expect=8e-06]} {Celegans: WBGene00000083, adt-2, ADAMTS family; ADAMTS-like protease, [Score=87.8, Expect=1e-16]} {Smed: dd_Smed_v6_628_0_1, dd_Smed_v6_628_0_1, [Score=159, Expect=6e-39]} {RNA1509_21415, RNA1509_6950} {RNA1310_548, RNA1509_21415, RNA1509_6950} {RNA1509_21415, RNA1509_6950, RNA815_300} |
20. | MligTC455_05554 | 54 | 1.12 | Mlig455_062512 | Neo: - Age: - |
0.99 | 0.990 | - | - | - | - | - | Mlig455_062512 {REF} {Length: 1169} {RNA1310_55738} {RNA815_31370.1} | |
21. | MligTC455_33475 | 168 | 3.5 | Mlig455_036879 | Neo: - Age: Down-Up-Down, logFC(26M/2M)=-0.551 Region-enriched R8: 7.210/0.00005 |
0.988 | 0.988 | - | - | - | - | - | Mlig455_036879 {REF} {Length: 2954} {RNA1509_20567} {RNA1310_1034.1} {RNA815_502.1} | |
22. | MligTC455_39971 | 147 | 3.07 | Mlig455_034549 | Neo: - Age: - Region-enriched R8: 4.475/0.00030 |
0.988 | 0.988 | - | - | - | - | - | Mlig455_034549 {REF} {Length: 2181} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=33.7]} {RNA1310_27858} {RNA815_17949} | |
23. | MligTC455_39972 | 142 | 2.96 | Mlig455_064814 | Neo: - Age: - Region-enriched R8: 4.539/0.00054 |
0.988 | 0.988 | - | - | - | - | - | Mlig455_064814 {REF} {Length: 2232} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=34.6]} {RNA1310_27858} {RNA815_17949} | |
24. | MligTC455_21451 | 352 | 7.34 | Mlig455_040118, Mlig455_067333 | Neo: - Age: - Region-enriched R8: 6.038/0.00000 |
ANGPTL7 | 0.986 | 0.986 | - | - | - | - | - | Mlig455_040118 {REF} {Length: 1728} {tRNA: Val(CAC),pseudo, score=20.9} {Pfam: Fibrinogen beta and gamma chains, C-terminal globular domain [PF00147.20, score=127.6]; PAN domain [PF00024.28, score=20.2]} {Human: ENSG00000171819, ANGPTL7, angiopoietin like 7, [Score=98.6, Expect=3e-23]; ENSG00000120332, TNN, tenascin N, [Score=98.2, Expect=2e-22]; ENSG00000171564, FGB, fibrinogen beta chain, [Score=96.7, Expect=5e-22]; ENSG00000116147, TNR, tenascin R, [Score=96.7, Expect=8e-22]; ENSG00000160339, FCN2, ficolin 2, [Score=94.0, Expect=5e-22]} {Mouse: ENSMUSG00000026725, Tnn, tenascin N, [Score=97.8, Expect=2e-22]; ENSMUSG00000015829, Tnr, tenascin R, [Score=97.8, Expect=2e-22]; ENSMUSG00000033831, Fgb, fibrinogen beta chain, [Score=95.9, Expect=5e-22]; ENSMUSG00000026938, Fcna, ficolin A, [Score=95.5, Expect=2e-22]; ENSMUSG00000028989, Angptl7, angiopoietin-like 7, [Score=94.0, Expect=8e-22]} {Dmel: FBgn0050280, CG30280, [Score=111, Expect=9e-29]} {Celegans: WBGene00020516, T15B7.1, [Score=68.2, Expect=6e-13]} {Smed: dd_Smed_v6_18326_0_1, dd_Smed_v6_18326_0_1, [Score=100, Expect=8e-24]} {RNA1509_58115} {RNA1310_32877} {RNA815_17241} Mlig455_067333 {REF} {Length: 1595} {Pfam: Fibrinogen beta and gamma chains, C-terminal globular domain [PF00147.20, score=128.2]; PAN domain [PF00024.28, score=20.3]} {Human: ENSG00000171819, ANGPTL7, angiopoietin like 7, [Score=99.8, Expect=1e-23]; ENSG00000120332, TNN, tenascin N, [Score=99.0, Expect=2e-22]; ENSG00000171564, FGB, fibrinogen beta chain, [Score=98.2, Expect=2e-22]; ENSG00000116147, TNR, tenascin R, [Score=97.1, Expect=7e-22]} {Mouse: ENSMUSG00000015829, Tnr, tenascin R, [Score=98.2, Expect=2e-22]; ENSMUSG00000026725, Tnn, tenascin N, [Score=97.8, Expect=3e-22]; ENSMUSG00000033831, Fgb, fibrinogen beta chain, [Score=97.4, Expect=2e-22]; ENSMUSG00000026938, Fcna, ficolin A, [Score=95.5, Expect=3e-22]; ENSMUSG00000028989, Angptl7, angiopoietin-like 7, [Score=94.4, Expect=6e-22]} {Dmel: FBgn0050280, CG30280, [Score=111, Expect=8e-29]} {Celegans: WBGene00020516, T15B7.1, [Score=68.6, Expect=6e-13]} {Smed: dd_Smed_v6_18326_0_1, dd_Smed_v6_18326_0_1, [Score=101, Expect=4e-24]} {RNA1509_58115} {RNA1310_32877} {RNA815_17241} |
25. | MligTC455_33925 | 519 | 10.82 | Mlig455_020716, Mlig455_020784 | Neo: - Age: Down-Down-Up Region-enriched R8: 6.564/0.00000 |
0.985 | 0.985 | - | - | - | - | - | Mlig455_020716 {REF} {Length: 1635} {Pfam: Amastin surface glycoprotein [PF07344.13, score=21.1]} {RNA1310_25321} {RNA815_36976} Mlig455_020784 {REF} {Length: 2274} {Pfam: Amastin surface glycoprotein [PF07344.13, score=22.1]} {RNA1310_25321} {RNA815_36976} |
|
26. | MligTC455_53279 | 2935 | 61.14 | Mlig455_017965 | Neo: - Age: Down-Up-Down Region-specific R8: 3.606 Region-enriched R8: 3.165/0.00000 Regeneration-downregulated BL: -2.902 Regeneration-depleted BL: -2.902 |
0.983 | 0.983 | - | - | - | - | - | Mlig455_017965 {REF} {Length: 1023} {RNA1509_20769, RNA1509_34269} {RNA1310_44808, RNA1509_20769, RNA1509_34269} {RNA1509_20769, RNA1509_34269, RNA815_8213} | |
27. | MligTC455_14600 | 206 | 4.29 | Mlig455_038122, Mlig455_039790 | Neo: - Age: - Region-enriched R8: 4.975/0.00049 |
IGFALS | 0.976 | 0.976 | - | - | - | - | - | Mlig455_038122 {REF} {Length: 2842} {Pfam: Leucine rich repeat [PF13855.8, score=265.7]; Leucine Rich repeats (2 copies) [PF12799.9, score=153.7]; Leucine-rich repeat [PF14580.8, score=67.1]; BspA type Leucine rich repeat region (6 copies) [PF13306.8, score=59.8]; Leucine Rich Repeat [PF00560.35, score=56.6]; Leucine Rich repeat [PF13516.8, score=43.5]} {Human: ENSG00000099769, IGFALS, insulin like growth factor binding protein acid labile subunit, [Score=156, Expect=3e-39]} {Mouse: ENSMUSG00000046070, Igfals, insulin-like growth factor binding protein, acid labile subunit, [RH, Score=160, Expect=8e-41]} {Dmel: FBgn0261269, conv, convoluted, [RH, Score=136, Expect=2e-32]} {Celegans: WBGene00016974, lron-15, ELRR (Extracellular Leucine-Rich Repeat) ONly, [RH, Score=149, Expect=1e-36]} {Smed: dd_Smed_v6_2769_0_1, dd_Smed_v6_2769_0_1, [RH, Score=95.9, Expect=2e-20]} {RNA1310_36223} {RNA815_24524} Mlig455_039790 {REF} {Length: 2820} {Pfam: Leucine rich repeat [PF13855.8, score=265.7]; Leucine Rich repeats (2 copies) [PF12799.9, score=153.7]; Leucine-rich repeat [PF14580.8, score=67.1]; BspA type Leucine rich repeat region (6 copies) [PF13306.8, score=59.8]; Leucine Rich Repeat [PF00560.35, score=56.6]; Leucine Rich repeat [PF13516.8, score=43.5]} {Human: ENSG00000099769, IGFALS, insulin like growth factor binding protein acid labile subunit, [Score=156, Expect=3e-39]} {Mouse: ENSMUSG00000046070, Igfals, insulin-like growth factor binding protein, acid labile subunit, [RH, Score=160, Expect=7e-41]} {Dmel: FBgn0261269, conv, convoluted, [RH, Score=135, Expect=2e-32]} {Celegans: WBGene00016974, lron-15, ELRR (Extracellular Leucine-Rich Repeat) ONly, [RH, Score=149, Expect=1e-36]} {Smed: dd_Smed_v6_2769_0_1, dd_Smed_v6_2769_0_1, [RH, Score=96.3, Expect=2e-20]} {RNA1310_36223} {RNA815_24524} |
28. | MligTC455_11926 | 101 | 2.11 | Mlig455_021319 | Neo: - Age: - Region-enriched R7: 4.905/0.00107 |
0.975 | 0.975 | - | - | - | - | - | Mlig455_021319 {REF} {Length: 2758} {Pfam: Mab-21 protein [PF03281.16, score=23.9]} {RNA1509_41055} {RNA1310_11481.1} {RNA815_44675} | |
29. | MligTC455_35051 | 220 | 4.58 | Mlig455_020175 | Neo: - Age: Down-Up-Down Region-enriched R8: 5.304/0.00000 |
CALM3 | 0.975 | 0.975 | - | - | - | - | - | Mlig455_020175 {REF} {Length: 927} {Pfam: EF hand [PF00036.34, score=111.3]; EF-hand domain pair [PF13499.8, score=98.6]; EF-hand domain [PF13405.8, score=91.1]; EF-hand domain pair [PF13833.8, score=78.1]; EF hand [PF13202.8, score=76.7]; EF-hand domain [PF14658.8, score=56.1]; Cytoskeletal-regulatory complex EF hand [PF12763.9, score=26.7]; Dockerin type I domain [PF00404.20, score=22.0]; EF-hand domain [PF17959.3, score=21.1]} {Human: ENSG00000160014, CALM3, calmodulin 3, [Score=146, Expect=5e-45]; ENSG00000198668, CALM1, calmodulin 1, [Score=146, Expect=5e-45]; ENSG00000143933, CALM2, calmodulin 2, [Score=146, Expect=5e-45]; ENSG00000178363, CALML3, calmodulin like 3, [Score=143, Expect=8e-44]} {Mouse: ENSMUSG00000001175, Calm1, calmodulin 1, [Score=146, Expect=3e-45]; ENSMUSG00000036438, Calm2, calmodulin 2, [Score=146, Expect=3e-45]; ENSMUSG00000019370, Calm3, calmodulin 3, [Score=146, Expect=3e-45]; ENSMUSG00000063130, Calml3, calmodulin-like 3, [Score=144, Expect=4e-44]} {Dmel: FBgn0000253, Cam, Calmodulin, [Score=148, Expect=8e-46]} {Celegans: WBGene00000552, cmd-1, Calmodulin, [Score=147, Expect=7e-46]} {Smed: dd_Smed_v6_255_0_1, dd_Smed_v6_255_0_1, [Score=147, Expect=5e-46]} {RNA1310_46966} {RNA815_26674} |
30. | MligTC455_21657 | 84 | 1.76 | Mlig455_048610 | Neo: - Age: - |
LMO1 | 0.972 | 0.972 | - | - | - | - | - | Mlig455_048610 {REF} {Length: 2071} {Pfam: LIM domain [PF00412.24, score=90.0]} {Human: ENSG00000166407, LMO1, LIM domain only 1, [RH, Score=186, Expect=1e-60]; ENSG00000048540, LMO3, LIM domain only 3, [RH, Score=183, Expect=2e-59]} {Mouse: ENSMUSG00000036111, Lmo1, LIM domain only 1, [RH, Score=183, Expect=1e-59]; ENSMUSG00000030226, Lmo3, LIM domain only 3, [RH, Score=183, Expect=1e-59]} {Dmel: FBgn0265598, Bx, Beadex, [RH, Score=198, Expect=1e-62]} {Celegans: WBGene00002987, lim-4, LIM domain family; Putative transcription factor LIM-4, [Score=79.3, Expect=7e-18]} {Smed: dd_Smed_v6_17422_0_1, dd_Smed_v6_17422_0_1, [RH, Score=140, Expect=6e-42]} {RNA1310_56294} {RNA815_40845} |
31. | MligTC455_30986 | 631 | 13.14 | Mlig455_010831, Mlig455_033221 | Neo: - Age: - Region-enriched R7: 2.524/0.00004 Regeneration-downregulated BL: -6.030 Regeneration-depleted BL: -6.030 |
PITPNC1 | 0.972 | 0.972 | - | - | - | - | - | Mlig455_010831 {REF} {Length: 1024} {Pfam: Phosphatidylinositol transfer protein [PF02121.20, score=91.8]} {Human: ENSG00000154217, PITPNC1, phosphatidylinositol transfer protein cytoplasmic 1, [Score=88.6, Expect=3e-21]} {Mouse: ENSMUSG00000040430, Pitpnc1, phosphatidylinositol transfer protein, cytoplasmic 1, [Score=89.0, Expect=1e-21]} {Dmel: FBgn0027872, rdgBbeta, [Score=91.3, Expect=2e-22]} {Celegans: WBGene00010813, pitp-1, PhosphatidylInositol Transfer Protein family, [Score=71.2, Expect=8e-15]} {Smed: dd_Smed_v6_580_0_1, dd_Smed_v6_580_0_1, [Score=65.9, Expect=2e-13]} {RNA1509_38619} {RNA1310_18833} {RNA815_8161} Mlig455_033221 {REF} {Length: 1640} {Pfam: Phosphatidylinositol transfer protein [PF02121.20, score=237.1]} {Human: ENSG00000154217, PITPNC1, phosphatidylinositol transfer protein cytoplasmic 1, [Score=144, Expect=4e-39]} {Mouse: ENSMUSG00000040430, Pitpnc1, phosphatidylinositol transfer protein, cytoplasmic 1, [Score=145, Expect=6e-40]} {Dmel: FBgn0027872, rdgBbeta, [Score=134, Expect=1e-35]} {Celegans: WBGene00010813, pitp-1, PhosphatidylInositol Transfer Protein family, [Score=111, Expect=1e-25]} {Smed: dd_Smed_v6_7211_0_2, dd_Smed_v6_7211_0_2, [Score=114, Expect=6e-27]} {RNA1509_38619} {RNA1310_18833} {RNA815_8161} |
32. | MligTC455_49843 | 70 | 1.46 | Mlig455_058264, Mlig455_058281, Mlig455_070786 | Neo: - Age: - |
CHRNA3, CHRNA7 | 0.972 | 0.972 | - | - | - | - | - | Mlig455_058264 {REF} {Length: 2377} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=149.4]; Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=103.7]} {Human: ENSG00000080644, CHRNA3, cholinergic receptor nicotinic alpha 3 subunit, [Score=224, Expect=4e-66]; ENSG00000274542, AC243734.1, cholinergic receptor nicotinic alpha 7 subunit, [Score=222, Expect=2e-65]; ENSG00000282088, AC254952.1, cholinergic receptor nicotinic alpha 7 subunit, [Score=222, Expect=2e-65]; ENSG00000175344, CHRNA7, cholinergic receptor nicotinic alpha 7 subunit, [Score=222, Expect=2e-65]; ENSG00000147434, CHRNA6, cholinergic receptor nicotinic alpha 6 subunit, [Score=216, Expect=2e-63]} {Mouse: ENSMUSG00000030525, Chrna7, cholinergic receptor, nicotinic, alpha polypeptide 7, [Score=223, Expect=8e-66]; ENSMUSG00000032303, Chrna3, cholinergic receptor, nicotinic, alpha polypeptide 3, [Score=220, Expect=8e-65]; ENSMUSG00000031492, Chrnb3, cholinergic receptor, nicotinic, beta polypeptide 3, [Score=219, Expect=6e-65]; ENSMUSG00000031491, Chrna6, cholinergic receptor, nicotinic, alpha polypeptide 6, [Score=213, Expect=4e-62]} {Dmel: FBgn0266347, nAChRalpha4, nicotinic Acetylcholine Receptor alpha4, [Score=240, Expect=3e-72]} {Celegans: WBGene00000060, acr-21, AcetylCholine Receptor, [Score=229, Expect=7e-69]} {Smed: dd_Smed_v6_31300_0_1, dd_Smed_v6_31300_0_1, [Score=227, Expect=1e-67]} {RNA1310_31785} {RNA815_40862} Mlig455_058281 {REF} {Length: 2912} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=179.9]; Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=105.5]} {Human: ENSG00000175344, CHRNA7, cholinergic receptor nicotinic alpha 7 subunit, [Score=239, Expect=1e-71]; ENSG00000274542, AC243734.1, cholinergic receptor nicotinic alpha 7 subunit, [Score=239, Expect=1e-71]; ENSG00000282088, AC254952.1, cholinergic receptor nicotinic alpha 7 subunit, [Score=238, Expect=4e-71]; ENSG00000080644, CHRNA3, cholinergic receptor nicotinic alpha 3 subunit, [Score=236, Expect=1e-70]; ENSG00000129749, CHRNA10, cholinergic receptor nicotinic alpha 10 subunit, [Score=231, Expect=2e-69]; ENSG00000174343, CHRNA9, cholinergic receptor nicotinic alpha 9 subunit, [Score=229, Expect=4e-68]} {Mouse: ENSMUSG00000030525, Chrna7, cholinergic receptor, nicotinic, alpha polypeptide 7, [Score=240, Expect=3e-72]; ENSMUSG00000032303, Chrna3, cholinergic receptor, nicotinic, alpha polypeptide 3, [Score=232, Expect=3e-69]; ENSMUSG00000029205, Chrna9, cholinergic receptor, nicotinic, alpha polypeptide 9, [Score=231, Expect=7e-69]; ENSMUSG00000066279, Chrna10, cholinergic receptor, nicotinic, alpha polypeptide 10, [Score=228, Expect=3e-68]} {Dmel: FBgn0266347, nAChRalpha4, nicotinic Acetylcholine Receptor alpha4, [Score=252, Expect=2e-76]} {Celegans: WBGene00000060, acr-21, AcetylCholine Receptor, [Score=250, Expect=1e-76]} {Smed: dd_Smed_v6_8058_0_1, dd_Smed_v6_8058_0_1, [Score=239, Expect=7e-72]} {RNA1310_31785} {RNA815_40862} Mlig455_070786 {REF} {Length: 1486} {Pfam: Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=36.1]} {RNA1310_31785} {RNA815_43410} |
33. | MligTC455_25854 | 1015 | 21.15 | Mlig455_052672 | Neo: - Age: logFC(26M/2M)=-0.640 Region-specific R8: 3.800 Region-enriched R8: 3.703/0.00000 Regeneration-downregulated BL: -2.563 Regeneration-depleted BL: -2.563 |
0.971 | 0.971 | - | - | - | - | - | Mlig455_052672 {REF} {Length: 1364} {Pfam: PLAC8 family [PF04749.19, score=60.9]} {Smed: dd_Smed_v6_865_0_1, dd_Smed_v6_865_0_1, [Score=98.2, Expect=1e-26]} {RNA1509_58157} {RNA1310_24348, RNA1509_58157} {RNA1509_58157, RNA815_10637.1} | |
34. | MligTC455_45987 | 1592 | 33.17 | Mlig455_024379, Mlig455_024495 | Neo: - Age: Up-Down-Down, logFC(26M/2M)=-0.664 Region-specific R8: 3.405 Region-enriched R8: 3.716/0.00000 Regeneration-depleted BL: -2.612 |
PKDREJ | 0.971 | 0.971 | - | - | - | - | - | Mlig455_024379 {REF} {Length: 9101} {Pfam: PKD domain [PF18911.2, score=34.9]; PKD domain [PF00801.22, score=21.5]} {RNA1509_1257} {RNA1310_126.1} {RNA815_58} Mlig455_024495 {REF} {Length: 8484} {Pfam: Polycystin cation channel [PF08016.14, score=333.9]; PLAT/LH2 domain [PF01477.25, score=69.5]; PKD domain [PF18911.2, score=32.8]; Ion transport protein [PF00520.33, score=31.6]; PKD domain [PF00801.22, score=19.8]} {Human: ENSG00000130943, PKDREJ, polycystin family receptor for egg jelly, [RH, Score=346, Expect=8e-95]} {Mouse: ENSMUSG00000052496, Pkdrej, polycystin (PKD) family receptor for egg jelly, [RH, Score=327, Expect=4e-89]; ENSMUSG00000034416, Pkd1l2, polycystic kidney disease 1 like 2, [RH, Score=319, Expect=7e-87]} {Dmel: FBgn0041195, Pkd2, Polycystic kidney disease 2, [Score=167, Expect=3e-41]} {Celegans: WBGene00004035, pkd-2, Polycystin-2, [Score=198, Expect=3e-52]} {Smed: dd_Smed_v6_10962_0_1, dd_Smed_v6_10962_0_1, [Score=592, Expect=9e-172]} {RNA1509_1257} {RNA1310_126.1} {RNA815_58} |
35. | MligTC455_41805 | 2256 | 47 | Mlig455_015764, Mlig455_049489 | Neo: - Age: - Region-specific R8: 2.792 Region-enriched R8: 2.927/0.00000 |
PKD2 | 0.969 | 0.969 | - | - | - | - | - | Mlig455_015764 {REF} {Length: 3347} {Pfam: Polycystin cation channel [PF08016.14, score=395.7]; Ion transport protein [PF00520.33, score=60.8]; EF hand [PF00036.34, score=22.8]; Ferredoxin I 4Fe-4S cluster domain [PF18109.3, score=20.9]} {Human: ENSG00000118762, PKD2, polycystin 2, transient receptor potential cation channel, [Score=618, Expect=0.0]} {Mouse: ENSMUSG00000034462, Pkd2, polycystic kidney disease 2, [Score=617, Expect=0.0]} {Dmel: FBgn0041195, Pkd2, Polycystic kidney disease 2, [Score=255, Expect=3e-72]} {Celegans: WBGene00004035, pkd-2, Polycystin-2, [Score=338, Expect=2e-104]} {Smed: dd_Smed_v6_17348_0_3, dd_Smed_v6_17348_0_3, [Score=660, Expect=0.0]} {RNA1509_31010} {RNA1310_4653.2} {RNA815_18688} Mlig455_049489 {REF} {Length: 3379} {Pfam: Polycystin cation channel [PF08016.14, score=493.3]; Ion transport protein [PF00520.33, score=89.5]; EF hand [PF00036.34, score=27.1]; Ferredoxin I 4Fe-4S cluster domain [PF18109.3, score=20.9]; EF-hand domain [PF13405.8, score=18.5]} {Human: ENSG00000118762, PKD2, polycystin 2, transient receptor potential cation channel, [RH, Score=716, Expect=0.0]} {Mouse: ENSMUSG00000034462, Pkd2, polycystic kidney disease 2, [RH, Score=711, Expect=0.0]} {Dmel: FBgn0041195, Pkd2, Polycystic kidney disease 2, [Score=306, Expect=1e-90]} {Celegans: WBGene00004035, pkd-2, Polycystin-2, [RH, Score=387, Expect=1e-122]} {Smed: dd_Smed_v6_17348_0_3, dd_Smed_v6_17348_0_3, [RH, Score=739, Expect=0.0]} {RNA1509_31010, RNA1509_51627} {RNA1310_4653.1, RNA1509_31010, RNA1509_51627} {RNA1509_31010, RNA1509_51627, RNA815_4316} |
36. | MligTC455_16918 | 1218 | 25.38 | Mlig455_039085, Mlig455_042780 | Neo: - Age: Up-Down-Down Region-enriched R8: 5.308/0.00000 |
MECOM | 0.968 | 0.968 | - | - | - | - | - | Mlig455_039085 {REF} {Length: 4916} {Pfam: Zinc finger, C2H2 type [PF00096.28, score=99.3]; C2H2-type zinc finger [PF13894.8, score=76.6]; Zinc-finger double domain [PF13465.8, score=72.4]; Zinc-finger double-stranded RNA-binding [PF12171.10, score=41.2]; C2H2-type zinc finger [PF13912.8, score=35.0]; Drought induced 19 protein (Di19), zinc-binding [PF05605.14, score=25.5]; Zinc-finger of C2H2 type [PF12874.9, score=20.9]; C2H2-type zinc-finger domain [PF13909.8, score=18.4]} {Human: ENSG00000085276, MECOM, MDS1 and EVI1 complex locus, [RH, Score=147, Expect=6e-35]; ENSG00000142611, PRDM16, PR/SET domain 16, [RH, Score=145, Expect=3e-34]} {Mouse: ENSMUSG00000027684, Mecom, MDS1 and EVI1 complex locus, [RH, Score=146, Expect=2e-35]; ENSMUSG00000039410, Prdm16, PR domain containing 16, [RH, Score=146, Expect=9e-35]} {Dmel: FBgn0045852, ham, hamlet, [RH, Score=149, Expect=1e-36]} {Celegans: WBGene00015646, mlt-10, [Score=172, Expect=3e-44]} {Smed: dd_Smed_v6_22685_0_1, dd_Smed_v6_22685_0_1, [RH, Score=145, Expect=5e-38]} {RNA1509_21422} {RNA1310_3577} {RNA815_16096} Mlig455_042780 {REF} {Length: 3778} {Pfam: Zinc finger, C2H2 type [PF00096.28, score=70.4]; Zinc-finger double domain [PF13465.8, score=59.4]; C2H2-type zinc finger [PF13894.8, score=36.4]; Drought induced 19 protein (Di19), zinc-binding [PF05605.14, score=29.7]; Zinc-finger double-stranded RNA-binding [PF12171.10, score=29.0]; C2H2-type zinc finger [PF13912.8, score=28.6]; Zinc-finger of C2H2 type [PF12874.9, score=24.8]; C2H2-type zinc-finger domain [PF13909.8, score=21.2]; GAGA factor [PF09237.13, score=19.5]; C2H2 type zinc-finger (2 copies) [PF12756.9, score=18.9]} {Human: ENSG00000085276, MECOM, MDS1 and EVI1 complex locus, [RH, Score=141, Expect=6e-35]; ENSG00000142611, PRDM16, PR/SET domain 16, [RH, Score=139, Expect=3e-34]} {Mouse: ENSMUSG00000027684, Mecom, MDS1 and EVI1 complex locus, [RH, Score=141, Expect=3e-35]; ENSMUSG00000039410, Prdm16, PR domain containing 16, [RH, Score=140, Expect=1e-34]} {Dmel: FBgn0032707, CG10348, [RH, Score=144, Expect=8e-37]} {Celegans: WBGene00001207, egl-43, Egl-43, [RH, Score=98.2, Expect=2e-22]} {Smed: dd_Smed_v6_22685_0_1, dd_Smed_v6_22685_0_1, [RH, Score=144, Expect=9e-39]} {RNA1509_21422} {RNA1310_3577} {RNA815_16096} |
37. | MligTC455_30985 | 442 | 9.22 | Mlig455_010824 | Neo: - Age: Down-Up-Down Region-enriched R7: 2.207/0.00023 Regeneration-downregulated BL: -3.092 Regeneration-depleted BL: -3.092 |
0.967 | 0.967 | - | - | - | - | - | Mlig455_010824 {REF} {Length: 2717} {Pfam: Pao retrotransposon peptidase [PF05380.15, score=178.4]; Family of unknown function (DUF5641) [PF18701.3, score=106.4]; Integrase zinc binding domain [PF17921.3, score=34.3]; Reverse transcriptase (RNA-dependent DNA polymerase) [PF00078.29, score=32.6]} {Celegans: WBGene00044435, Y20F4.8, [Score=64.7, Expect=9e-11]} {Smed: dd_Smed_v6_22202_0_1, dd_Smed_v6_22202_0_1, [RH, Score=119, Expect=5e-31]} {RNA1509_9219} {RNA1310_468} {RNA815_355.1} | |
38. | MligTC455_15983 | 668 | 13.92 | Mlig455_018780, Mlig455_018950 | Neo: - Age: Up-Down-Down Region-enriched R8: 4.299/0.00000 |
0.966 | 0.966 | - | - | - | - | - | Mlig455_018780 {REF} {Length: 1496} {RNA1509_47436} {RNA1310_22809.1} {RNA815_49713} Mlig455_018950 {REF} {Length: 1264} {RNA1509_47436} {RNA1310_22809.1, RNA1509_47436} {RNA1509_47436, RNA815_49713} |
|
39. | MligTC455_22230 | 170 | 3.54 | Mlig455_013703, Mlig455_013720 | Neo: - Age: Down-Up-Down Region-enriched R8: 5.137/0.00004 |
0.966 | 0.966 | - | - | - | - | - | Mlig455_013703 {REF} {Length: 2025} {RNA1509_49155} {RNA1310_23836, RNA1509_49155} {RNA1509_49155, RNA815_28676} Mlig455_013720 {REF} {Length: 2031} {RNA1509_49155} {RNA1310_23836} {RNA815_28676} |
|
40. | MligTC455_46216 | 1117 | 23.28 | Mlig455_057440 | Neo: - Age: - Region-enriched R7: 2.350/0.00017 |
RBPMS2 | 0.965 | 0.965 | - | - | - | - | - | Mlig455_057440 {REF} {Length: 4543} {TRANSSPLICED} {Pfam: RNA recognition motif. (a.k.a. RRM, RBD, or RNP domain) [PF00076.24, score=53.4]} {Human: ENSG00000166831, RBPMS2, RNA binding protein, mRNA processing factor 2, [RH, Score=128, Expect=2e-35]} {Mouse: ENSMUSG00000031586, Rbpms, RNA binding protein gene with multiple splicing, [RH, Score=125, Expect=3e-35]} {Dmel: FBgn0263995, cpo, couch potato, [Score=164, Expect=7e-46]} {Celegans: WBGene00003172, mec-8, Mec-8 protein, [Score=124, Expect=4e-33]} {Smed: dd_Smed_v6_4296_0_4, dd_Smed_v6_4296_0_4, [Score=150, Expect=3e-43]} {RNA1509_30119} {RNA1310_16586.1} {RNA815_23894} |
41. | MligTC455_40184 | 660 | 13.74 | Mlig455_004167, Mlig455_004192 | Neo: - |
0.964 | - | - | - | - | 0.964 | - | Mlig455_004167 {REF} {Length: 1157} {RNA1509_29172, RNA1509_51059} {RNA1310_10204, RNA1509_29172, RNA1509_51059} {RNA1509_29172, RNA1509_51059, RNA815_19579} Mlig455_004192 {REF} {Length: 887} {RNA1509_51059, RNA1509_60087} {RNA1310_10204, RNA1509_60087} {RNA1509_60087, RNA815_19579} |
|
42. | MligTC455_46106 | 17 | 0.35 | Mlig455_005750 | Neo: - Age: - |
NEUROD1 | 0.964 | - | - | - | - | 0.964 | - | Mlig455_005750 {REF} {Length: 2658} {Pfam: Helix-loop-helix DNA-binding domain [PF00010.28, score=57.3]} {Human: ENSG00000162992, NEUROD1, neuronal differentiation 1, [Score=63.9, Expect=1e-10]; ENSG00000123307, NEUROD4, neuronal differentiation 4, [Score=63.2, Expect=2e-10]; ENSG00000181965, NEUROG1, neurogenin 1, [Score=62.8, Expect=1e-10]; ENSG00000146618, FERD3L, Fer3 like bHLH transcription factor, [Score=62.8, Expect=3e-11]; ENSG00000168267, PTF1A, pancreas associated transcription factor 1a, [Score=61.6, Expect=5e-10]; ENSG00000171532, NEUROD2, neuronal differentiation 2, [Score=61.2, Expect=9e-10]; ENSG00000260428, SCX, scleraxis bHLH transcription factor, [Score=60.8, Expect=3e-10]; ENSG00000125878, TCF15, transcription factor 15, [Score=60.8, Expect=3e-10]} {Mouse: ENSMUSG00000048015, Neurod4, neurogenic differentiation 4, [Score=65.1, Expect=3e-11]; ENSMUSG00000068079, Tcf15, transcription factor 15, [Score=64.7, Expect=1e-11]; ENSMUSG00000034701, Neurod1, neurogenic differentiation 1, [Score=63.9, Expect=8e-11]; ENSMUSG00000046518, Ferd3l, Fer3 like bHLH transcription factor, [Score=63.5, Expect=1e-11]; ENSMUSG00000048904, Neurog1, neurogenin 1, [Score=62.8, Expect=8e-11]} {Dmel: FBgn0037475, Fer1, 48 related 1, [Score=70.9, Expect=1e-13]} {Celegans: WBGene00001954, hlh-10, Helix Loop Helix, [RH, Score=57.0, Expect=2e-09]} {Smed: dd_Smed_v6_6869_0_1, dd_Smed_v6_6869_0_1, [RH, Score=68.2, Expect=2e-13]} {RNA1310_27559} {RNA815_55155} |
43. | MligTC455_01611 | 16 | 0.34 | Mlig455_068799 | Neo: - Age: - |
0.963 | - | - | - | - | 0.963 | - | Mlig455_068799 {REF} {Length: 263} {NoTransDecoderORF} | |
44. | MligTC455_15731 | 36 | 0.76 | Mlig455_045491 | Neo: - Age: - |
0.963 | - | - | - | - | 0.963 | - | Mlig455_045491 {REF} {Length: 560} {NoTransDecoderORF} {RNA1509_38091} {RNA1310_15069.1} {RNA815_11643} | |
45. | MligTC455_22067 | 76 | 1.59 | Mlig455_001752, Mlig455_001775 | Neo: Irradiation Age: Up-Down-Down Region-enriched R5: 4.257/0.00021 |
NANOS1 | 0.962 | - | - | - | - | 0.962 | - | Mlig455_001752 {REF} {Length: 2806} {Pfam: Nanos RNA binding domain [PF05741.15, score=79.7]} {Human: ENSG00000188613, NANOS1, nanos C2HC-type zinc finger 1, [RH, Score=82.4, Expect=2e-17]; ENSG00000188425, NANOS2, nanos C2HC-type zinc finger 2, [RH, Score=81.6, Expect=2e-18]} {Mouse: ENSMUSG00000072437, Nanos1, nanos C2HC-type zinc finger 1, [RH, Score=83.2, Expect=5e-18]; ENSMUSG00000051965, Nanos2, nanos C2HC-type zinc finger 2, [RH, Score=79.3, Expect=1e-17]} {Dmel: FBgn0002962, nos, Nitric oxide synthase, [Score=74.7, Expect=9e-15]} {Smed: dd_Smed_v6_10484_0_1, dd_Smed_v6_10484_0_1, [RH, Score=114, Expect=6e-30]} {RNA1310_14325} {RNA815_45506} Mlig455_001775 {REF} {Length: 2572} {Pfam: Nanos RNA binding domain [PF05741.15, score=79.5]} {Human: ENSG00000188613, NANOS1, nanos C2HC-type zinc finger 1, [RH, Score=82.4, Expect=3e-17]; ENSG00000188425, NANOS2, nanos C2HC-type zinc finger 2, [RH, Score=81.6, Expect=3e-18]} {Mouse: ENSMUSG00000072437, Nanos1, nanos C2HC-type zinc finger 1, [RH, Score=83.2, Expect=1e-17]; ENSMUSG00000051965, Nanos2, nanos C2HC-type zinc finger 2, [RH, Score=79.7, Expect=1e-17]} {Dmel: FBgn0002962, nos, Nitric oxide synthase, [Score=73.9, Expect=3e-14]} {Smed: dd_Smed_v6_10484_0_1, dd_Smed_v6_10484_0_1, [RH, Score=113, Expect=3e-29]} {RNA1310_14325} {RNA815_51586} |
46. | MligTC455_48954 | 316 | 6.59 | Mlig455_000336, Mlig455_067936 | Neo: - Age: - Region-enriched R8: 6.016/0.00000 |
WNT2 | 0.961 | 0.961 | - | - | - | - | - | Mlig455_000336 {REF} {Length: 2268} {Pfam: wnt family [PF00110.21, score=150.7]} {Human: ENSG00000105989, WNT2, Wnt family member 2, [Score=94.4, Expect=1e-20]; ENSG00000162552, WNT4, Wnt family member 4, [Score=92.8, Expect=3e-20]} {Mouse: ENSMUSG00000010797, Wnt2, wingless-type MMTV integration site family, member 2, [Score=95.1, Expect=4e-21]; ENSMUSG00000036856, Wnt4, wingless-type MMTV integration site family, member 4, [Score=93.2, Expect=2e-20]} {Dmel: FBgn0010453, Wnt4, Wnt oncogene analog 4, [Score=75.5, Expect=3e-14]} {Celegans: WBGene00000857, cwn-1, [Score=95.5, Expect=2e-21]} {Smed: dd_Smed_v6_14391_0_1, dd_Smed_v6_14391_0_1, [RH, Score=137, Expect=4e-36]} {RNA1509_39977} {RNA1310_11459, RNA1509_39977} {RNA1509_39977, RNA815_18855} Mlig455_067936 {REF} {Length: 2361} {Pfam: wnt family [PF00110.21, score=149.2]} {Human: ENSG00000105989, WNT2, Wnt family member 2, [Score=96.7, Expect=2e-21]; ENSG00000162552, WNT4, Wnt family member 4, [Score=92.0, Expect=6e-20]} {Mouse: ENSMUSG00000010797, Wnt2, wingless-type MMTV integration site family, member 2, [Score=97.4, Expect=7e-22]} {Dmel: FBgn0010453, Wnt4, Wnt oncogene analog 4, [Score=75.5, Expect=3e-14]} {Celegans: WBGene00000857, cwn-1, [Score=96.3, Expect=1e-21]} {Smed: dd_Smed_v6_14391_0_1, dd_Smed_v6_14391_0_1, [RH, Score=133, Expect=7e-35]} {RNA1509_39977} {RNA1310_11459} {RNA815_18855} |
47. | MligTC455_46217 | 213 | 4.43 | Mlig455_057532 | Neo: - Age: Down-Up-Down |
RBPMS2 | 0.96 | 0.960 | - | - | - | - | - | Mlig455_057532 {REF} {Length: 5470} {Pfam: RNA recognition motif. (a.k.a. RRM, RBD, or RNP domain) [PF00076.24, score=53.4]} {Human: ENSG00000166831, RBPMS2, RNA binding protein, mRNA processing factor 2, [RH, Score=128, Expect=2e-35]} {Mouse: ENSMUSG00000031586, Rbpms, RNA binding protein gene with multiple splicing, [RH, Score=125, Expect=3e-35]} {Dmel: FBgn0263995, cpo, couch potato, [Score=164, Expect=7e-46]} {Celegans: WBGene00003172, mec-8, Mec-8 protein, [Score=124, Expect=4e-33]} {Smed: dd_Smed_v6_4296_0_4, dd_Smed_v6_4296_0_4, [Score=150, Expect=3e-43]} {RNA1509_30119} {RNA1310_16586.1} {RNA815_23894} |
48. | MligTC455_47410 | 144 | 3 | Mlig455_066471 | Neo: - Age: - |
0.96 | 0.960 | - | - | - | - | - | Mlig455_066471 {REF} {Length: 690} {NoTransDecoderORF} {RNA1509_9488} {RNA1310_3197} {RNA815_3130} | |
49. | MligTC455_18853 | 111 | 2.31 | Mlig455_003980 | Neo: - Age: Down-Down-Down Region-enriched R5: 2.394/0.01639 |
MRPL45 | 0.956 | - | - | - | - | 0.956 | - | Mlig455_003980 {REF} {Length: 1097} {TRANSSPLICED} {Human: ENSG00000278845, MRPL45, mitochondrial ribosomal protein L45, [RH, Score=62.0, Expect=2e-10]; ENSG00000277936, MRPL45, mitochondrial ribosomal protein L45, [RH, Score=62.0, Expect=2e-10]} {Mouse: ENSMUSG00000018882, Mrpl45, mitochondrial ribosomal protein L45, [RH, Score=57.8, Expect=4e-09]} {Dmel: FBgn0263863, mRpL45, mitochondrial ribosomal protein L45, [RH, Score=73.9, Expect=1e-14]} {Celegans: WBGene00022493, mrpl-45, Probable 39S ribosomal protein L45, mitochondrial, [RH, Score=75.1, Expect=3e-15]} {Smed: dd_Smed_v6_2740_0_1, dd_Smed_v6_2740_0_1, [RH, Score=64.3, Expect=8e-12]} {RNA1509_6788} {RNA1310_30839} {RNA815_14208} |
50. | MligTC455_04420 | 209 | 4.36 | Mlig455_005696 | Neo: - Age: - Region-enriched R7: 3.482/0.00030 |
0.955 | 0.955 | - | - | - | - | - | Mlig455_005696 {REF} {Length: 2113} {Pfam: Major Facilitator Superfamily [PF07690.18, score=68.2]; PUCC protein [PF03209.17, score=38.1]; MFS/sugar transport protein [PF13347.8, score=25.9]; MFS_1 like family [PF12832.9, score=24.5]} {Smed: dd_Smed_v6_8550_0_1, dd_Smed_v6_8550_0_1, [Score=388, Expect=2e-131]} {RNA1509_18256} {RNA1310_12968} {RNA815_5192} | |
51. | MligTC455_24264 | 359 | 7.48 | Mlig455_023846, Mlig455_046531 | Neo: - Age: - |
0.955 | - | - | - | - | 0.955 | - | Mlig455_023846 {REF} {Length: 722} {NoTransDecoderORF} {RNA1509_48720} {RNA1310_8026} {RNA815_3300.1} Mlig455_046531 {REF} {Length: 436} {NoTransDecoderORF} {RNA1509_56940} {RNA1310_8026} {RNA815_3300.1} |
|
52. | MligTC455_46547 | 101 | 2.11 | Mlig455_013892 | Neo: - Age: - Region-enriched R6: 3.545/0.03138 |
0.955 | - | - | - | - | 0.955 | - | Mlig455_013892 {REF} {Length: 829} {TRANSSPLICED} {NoTransDecoderORF} {RNA1509_57449} {RNA1310_78138} {RNA815_50926} | |
53. | MligTC455_25852 | 257 | 5.35 | Mlig455_026376 | Neo: - Age: Down-Up-Down Region-enriched R7: 2.913/0.04400 |
0.954 | 0.954 | - | - | - | - | - | Mlig455_026376 {REF} {Length: 1440} {Pfam: PLAC8 family [PF04749.19, score=60.9]} {Smed: dd_Smed_v6_865_0_1, dd_Smed_v6_865_0_1, [Score=98.2, Expect=1e-26]} {RNA1509_36976} {RNA1310_18646} {RNA815_10637.1} | |
54. | MligTC455_26535 | 92 | 1.91 | Mlig455_028631 | Neo: - Age: logFC(26M/2M)=-0.989 |
0.954 | - | - | - | - | 0.954 | - | Mlig455_028631 {REF} {Length: 2945} {TRANSSPLICED} {Pfam: Guanine nucleotide exchange factor synembryn [PF10165.11, score=55.1]} {RNA1509_37009, RNA1509_38508} {RNA1310_10694.2, RNA1509_37009, RNA1509_38508} {RNA1509_37009, RNA1509_38508, RNA815_4977} | |
55. | MligTC455_04474 | 114 | 2.37 | Mlig455_039605 | Neo: - Age: logFC(26M/2M)=-0.389 Region-enriched R8: 5.608/0.00012 |
HMCN1 | 0.953 | 0.953 | - | - | - | - | - | Mlig455_039605 {REF} {Length: 4319} {Pfam: Thrombospondin type 1 domain [PF00090.21, score=405.5]; Spondin-like TSP1 domain [PF19028.2, score=340.3]; Thrombospondin type 1 domain [PF19030.2, score=125.1]; Scavenger receptor cysteine-rich domain [PF00530.20, score=57.7]; CCN3 Nov like TSP1 domain [PF19035.2, score=48.4]} {Human: ENSG00000143341, HMCN1, hemicentin 1, [Score=292, Expect=4e-80]} {Mouse: ENSMUSG00000066842, Hmcn1, hemicentin 1, [Score=288, Expect=7e-79]} {Dmel: FBgn0284221, Sema5c, Semaphorin 5c, [Score=156, Expect=3e-38]} {Celegans: WBGene00016468, C36B7.5, [RH, Score=199, Expect=7e-52]} {Smed: dd_Smed_v6_1161_0_1, dd_Smed_v6_1161_0_1, [Score=264, Expect=9e-72]} {RNA1509_12135} {RNA1310_3277, RNA1509_12135} {RNA1509_12135, RNA815_5276} |
56. | MligTC455_31323 | 119 | 2.48 | Mlig455_064684 | Neo: - Age: - |
ACP2 | 0.952 | - | - | - | - | 0.952 | - | Mlig455_064684 {REF} {Length: 3113} {TRANSSPLICED} {Pfam: Histidine phosphatase superfamily (branch 2) [PF00328.24, score=78.1]} {Human: ENSG00000134575, ACP2, acid phosphatase 2, lysosomal, [Score=179, Expect=4e-51]} {Mouse: ENSMUSG00000002103, Acp2, acid phosphatase 2, lysosomal, [Score=185, Expect=3e-53]} {Dmel: FBgn0000032, Acph-1, Acid phosphatase 1, [Score=173, Expect=6e-49]} {Celegans: WBGene00015161, pho-5, Putative acid phosphatase 5, [RH, Score=169, Expect=9e-48]} {Smed: dd_Smed_v6_11594_0_1, dd_Smed_v6_11594_0_1, [RH, Score=179, Expect=6e-51]} {RNA1509_29407} {RNA1310_15922, RNA1509_29407} {RNA1509_29407, RNA815_8033} |
57. | MligTC455_40223 | 172 | 3.59 | Mlig455_016264 | Neo: - Age: - Region-enriched R8: 3.704/0.01076 |
CHRNA10 | 0.952 | 0.952 | - | - | - | - | - | Mlig455_016264 {REF} {Length: 4782} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=169.5]; Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=109.0]} {Human: ENSG00000129749, CHRNA10, cholinergic receptor nicotinic alpha 10 subunit, [Score=230, Expect=2e-68]; ENSG00000147432, CHRNB3, cholinergic receptor nicotinic beta 3 subunit, [Score=225, Expect=1e-66]} {Mouse: ENSMUSG00000031492, Chrnb3, cholinergic receptor, nicotinic, beta polypeptide 3, [Score=233, Expect=9e-70]} {Dmel: FBgn0032151, nAChRalpha6, nicotinic Acetylcholine Receptor alpha6, [Score=236, Expect=2e-70]} {Celegans: WBGene00000060, acr-21, AcetylCholine Receptor, [Score=215, Expect=6e-63]} {Smed: dd_Smed_v6_31300_0_1, dd_Smed_v6_31300_0_1, [Score=280, Expect=9e-87]} {RNA1509_35668} {RNA1310_11720.1} {RNA815_6827} |
58. | MligTC455_28455 | 35 | 0.74 | Mlig455_035827 | Neo: - Age: - |
ERG | 0.951 | - | - | - | - | 0.951 | - | Mlig455_035827 {REF} {Length: 3020} {Pfam: Ets-domain [PF00178.24, score=117.6]; Transcription factor IIA, alpha/beta subunit [PF03153.15, score=20.6]} {Human: ENSG00000157554, ERG, ERG, ETS transcription factor, [Score=192, Expect=1e-56]; ENSG00000151702, FLI1, Fli-1 proto-oncogene, ETS transcription factor, [Score=189, Expect=7e-58]} {Mouse: ENSMUSG00000040732, Erg, ETS transcription factor, [Score=192, Expect=7e-57]; ENSMUSG00000016087, Fli1, Friend leukemia integration 1, [Score=189, Expect=8e-56]} {Dmel: FBgn0005658, Ets65A, Ets at 65A, [Score=187, Expect=3e-57]} {Celegans: WBGene00020368, ast-1, Axon STeering defect, [RH, Score=188, Expect=2e-56]} {Smed: dd_Smed_v6_11113_0_1, dd_Smed_v6_11113_0_1, [Score=176, Expect=8e-52]} {RNA1509_45348} {RNA1310_139406} {RNA815_32211} |
59. | MligTC455_38303 | 142 | 2.96 | Mlig455_021803 | Neo: - Age: Up-Down-Down |
PCLO | 0.951 | 0.951 | - | - | - | - | - | Mlig455_021803 {REF} {Length: 6090} {Pfam: C2 domain [PF00168.32, score=66.7]; FYVE-type zinc finger [PF02318.18, score=55.2]; Piccolo Zn-finger [PF05715.15, score=27.5]} {Human: ENSG00000186472, PCLO, piccolo presynaptic cytomatrix protein, [RH, Score=122, Expect=6e-27]} {Mouse: ENSMUSG00000061601, Pclo, piccolo (presynaptic cytomatrix protein), [RH, Score=119, Expect=2e-26]} {Dmel: FBgn0053547, Rim, Rab3 interacting molecule, [Score=83.2, Expect=1e-15]} {Celegans: WBGene00004033, pkc-2, Protein kinase C-like 2, [Score=79.0, Expect=1e-14]} {Smed: dd_Smed_v6_9615_0_1, dd_Smed_v6_9615_0_1, [RH, Score=185, Expect=4e-47]} {RNA1509_42665} {RNA1310_6999} {RNA815_17846} |
60. | MligTC455_51937 | 465 | 9.7 | Mlig455_000671 | Neo: - Age: Down-Up-Up |
BBIP1 | 0.951 | - | - | - | - | 0.951 | - | Mlig455_000671 {REF} {Length: 795} {TRANSSPLICED} {Pfam: Cilia BBSome complex subunit 10 [PF14777.8, score=81.5]} {Human: ENSG00000214413, BBIP1, BBSome interacting protein 1, [RH, Score=58.9, Expect=1e-12]} {Mouse: ENSMUSG00000084957, Bbip1, BBSome interacting protein 1, [RH, Score=59.3, Expect=3e-13]} {Dmel: FBgn0260237, CG42511, [RH, Score=40.4, Expect=6e-06]} {Celegans: WBGene00019482, K07C11.10, [RH, Score=43.5, Expect=8e-07]} {Smed: dd_Smed_v6_12991_0_1, dd_Smed_v6_12991_0_1, [Score=59.3, Expect=2e-13]} {RNA1509_11275, RNA1509_30377} {RNA1310_33550, RNA1509_11275, RNA1509_30377} {RNA1509_11275, RNA1509_30377, RNA815_15542} |
61. | MligTC455_37269 | 173 | 3.61 | Mlig455_020047 | Neo: - Age: - |
CASP3 | 0.95 | 0.950 | - | - | - | - | - | Mlig455_020047 {REF} {Length: 2828} {Pfam: Caspase domain [PF00656.24, score=94.7]; Ankyrin repeats (3 copies) [PF12796.9, score=79.1]; Ankyrin repeats (many copies) [PF13857.8, score=62.0]; Ankyrin repeats (many copies) [PF13637.8, score=58.0]; Ankyrin repeat [PF13606.8, score=40.7]; Ankyrin repeat [PF00023.32, score=31.7]} {Human: ENSG00000164305, CASP3, caspase 3, [Score=111, Expect=1e-26]; ENSG00000003400, CASP10, caspase 10, [Score=107, Expect=9e-24]} {Mouse: ENSMUSG00000031628, Casp3, caspase 3, [Score=106, Expect=5e-25]; ENSMUSG00000025076, Casp7, caspase 7, [Score=106, Expect=7e-25]} {Dmel: FBgn0010501, Dcp-1, Death caspase-1, [Score=96.3, Expect=2e-21]} {Celegans: WBGene00000417, ced-3, Cell death protein 3 Cell death protein 3 subunit 1 Cell death protein 3 subunit 2, [Score=81.6, Expect=9e-17]} {Smed: dd_Smed_v6_10883_0_1, dd_Smed_v6_10883_0_1, [Score=107, Expect=1e-24]} {RNA1509_54818} {RNA1310_7187} {RNA815_8712} |